Page last updated on March 31, 2025
NIKA PHARMACEUTICALS, INC reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-31 13:45:42 EDT.
Filings
10-K filed on 2025-03-31
NIKA PHARMACEUTICALS, INC filed a 10-K at 2025-03-31 13:45:42 EDT
Accession Number: 0001826466-25-000030
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
ITEM 1C. CYBERSECURITY The Company does not have any processes for identifying and managing material risks from cybersecurity threats. The Company considers that at the current stages of its development and information systems there are no risks of cybersecurity incidents that have materially affected and are reasonably likely to materially affect the company, including its business strategy, results of operations, or financial condition. Because the Company is not reasonably likely to be materially affected by cybersecurity threats at the current stages of its development, there are no particular director’s oversight of risks from cybersecurity threats and management does not have an active role in assessing and managing the Company’s material risks from cybersecurity threats.
Company Information
| Name | NIKA PHARMACEUTICALS, INC |
| CIK | 0001145604 |
| SIC Description | Pharmaceutical Preparations |
| Ticker | NIKA - OTC |
| Website | |
| Category | Non-accelerated filer Smaller reporting company Emerging growth company |
| Fiscal Year End | December 30 |